Ginkgo Bioworks Announces Date of First Quarter 2022 Results Presentation
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session on May 16, 2022, at 4:30 p.m. ET, to review its first-quarter performance ending March 31, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session on May 16, 2022, at 4:30 p.m. ET, to review its first-quarter performance ending March 31, 2022. The session will be accessible via Ginkgo's investor relations website, where a replay will also be available. This meeting aims to provide investors with insights into Ginkgo's business metrics and future projections, reinforcing its position in the biotechnology sector with applications in various markets including food, agriculture, and pharmaceuticals.
Positive
- Scheduled Q&A session provides transparent communication to shareholders.
- Business performance review indicates Ginkgo's commitment to investor relations.
Negative
- None.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was -12.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Presentation and Q&A session scheduled for post-market on Monday, May 16, 2022
BOSTON, May 9, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2022, on Monday, May 16, 2022, beginning at 4:30 p.m. ET.
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2022-results-presentation-301542271.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.